60 /100
HIGH RISK
Score updated Jul 14, 2026

ARAI — Arrive AI Inc. Dilution Risk Tracker

Track ARAI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ARAI — Get alerts when the score changes →

As of July 14, 2026, Arrive AI Inc. (ARAI) has a DilutionWatch DilutionScore of 60/100, rated HIGH dilution risk. Arrive AI Inc. has a market capitalization of $34.23M, 51.86M shares outstanding, 10 institutional holders tracked. Key dilution vectors include shelf registration capacity of $10.00M, ATM program capacity of $10.00M, approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
71
💰 Cash Runway
0
📊 Float Risk
55
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
54%
🔁 Convertible Conversion 60%
• Major convertible overhang: 32% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split 55%
• 50-day avg $0.78 below $1 exchange minimum
💰 Capital Raise 38%
• Active shelf registration ($10M, 29% of market cap)
• Active ATM program with $10M remaining capacity
🔔 Track ARAI — Get forecast alerts →

💹 Market Data

Market Cap$34.23M
Shares Outstanding51.86M
Float22.40M
Cash$16.40B
Debt$9.71M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 492.6K shares
#1 Geode Capital Management, LLC 123.6K shares
#2 Vanguard Group Inc 103.2K shares
#3 Blackrock Inc. 91.2K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest722.5K
Days to Cover1.1
% of Float3.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Mar 31, 2026
4 INSIDER TRANSACTION Jul 07, 2026
4 INSIDER TRANSACTION Jul 07, 2026
4 INSIDER TRANSACTION Jul 07, 2026
Full SEC filing analysis available with free account

📰 Recent News

📋 What This Means for ARAI Shareholders

Arrive AI Inc. (ARAI) has a DilutionScore of 60/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

The most significant dilution vector for ARAI is its shelf registration capacity of $10.0M. A shelf registration (typically an S-3 filing) gives a company pre-approved access to raise capital quickly without a traditional roadshow. The registered amount represents the maximum that can be raised — not necessarily what will be raised — but active shelves combined with tight cash positions are the pattern DilutionWatch monitors most closely. ARAI has an active ATM (at-the-market) program with $10.0M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event.

DilutionWatch tracks over 25 SEC filing types for ARAI in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for ARAI alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding Shelf Registrations → How ATM Offerings Work →
Track ARAI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ARAI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ARAI
📊 ARAI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ARAI Signal Convergence & Dark Pool Activity — StonkWhisper 📄 ARAI Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.